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Background: Seroma formation is the most common complication after breast cancer surgery. It is an important
complication since it prolongs therapy duration, increases cost, and negatively affects patient psychology. Currently,
there is no widely accepted method that prevents seroma formation. We tried to investigate impact of local
phenytoin application on seroma formation following an experimental mastectomy model created in rats.
Methods: Two groups including eight rats in each were randomized. Saline injection was applied in the first group,
whereas 1% phenytoin was locally used in the second group. Ten days after the surgery, seroma formation and
wound-healing processes were evaluated using histopathological and biochemical examinations.
Results: Phenytoin significantly decreased seroma formation. Fibrosis was significantly increased and angiogenesis
was significantly reduced in the phenytoin group (P < 0.05). Increased levels of macrophage and lymphocyte
infiltration was detected in the control group (P < 0.05). No difference was detected between the groups in terms
of necrosis, edema, congestion, and PNL (Polymorphonuclear leucocyte) and fibroblast infiltration.
Conclusions: Seroma formation-reducing effect of phenytoin might have occurred over its anti-inflammatory, anti-
angiogenetic, and fibrosis augmenting effects.
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Seroma formation isone of the most common complica-
tions after breast cancer surgery. It has been reported
that seroma occurs by 5-52% after modified radical
mastectomy (MRM) procedure and by 7.1-14% after sen-
tinel lymph node biopsy (SLNB) [1-5].
Seroma formation usually disappears following surgery
within a few weeks. But sometimes it may persist for a
few months. Prolonged therapy duration and require-
ment for multiple aspirations may cause trouble for
patients, and more importantly it can delay adjuvant
therapy and may cause increasement of treatment costs.
We believe flaps are lightly attached to chest wall, and
additionaly perioperative dissection may harm lymphatic* Correspondence: mkement@yahoo.com
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reproduction in any medium, provided the orand capillary vessels. Large dead space, auxillary effects
of muscles to venous return may be interrupted during
surgery. Finally shape of the axilla and chest wall, local
inflammatory mediators and all factors mentioned above
are considered responsible for seroma formation [2].
Seroma formation is seen more likely in overweight
patients, patients that underwent modified radical mast-
ectomy as opposed to simple mastectomy, and in those
with increased amount of drainage within the first three
days of surgery [3]. Rather than treatment of seroma,
due to ineffective therapy methods, surgeons directed
their interests to prevent formation. One of the best
methods in preventing seroma formation is to get rid of
dead-space. Meticulous dissection and application of
various medical agents may accelerate wound healing
and fibrosis. Despite certain success rates obtained by
improvement of surgical techniques and usage of fibrin
glue, these therapy modalities have failed to become. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that phenytoin, which is an antiepileptic agent, has also
antibacterial effect, which can accelerate wound healing
and reduce pain [9,10]. The present study aimed to in-
vestigate the effect of local phenytoin application on ser-
oma formation in an experimental mastectomy and
ALND model in rats.
Methods
Sixteen female Wistar Albino rats (mean weight 220 g)
were utilized in the present study. Approval of Istanbul
Yeditepe University of Medical Faculty, Ethical Commit-
tee on Experimental Animal Research was obtained
(2011–186). Animals were obtained from the Experi-
mental Animals Laboratory of Istanbul Yeditepe Uni-
versity of Medical Faculty. All rats were fed with
standard laboratory food and water [rodent chow ad
libitum] and monitored in an isolated place, which had
controlled heat (22 ± 2°C) and was illuminated as 12-
hour night/day cycle. Surgeries were performed in
Istanbul Yeditepe University of Medical Faculty Experi-
mental Animals Laboratory under non-sterile but clean
conditions. Preoperative prophylactic antibiotics were
not used to avoid drug interaction. Animals were
weighed prior to the surgery. A sterile form of 1%
phenytoin in normal saline was prepared. Exclusion cri-
teria were determined as follows: flap necrosis, wound
dehiscence, infection, and death. Ketamine (KetalarW,
Parke Davis and Co. Inc. USA, 50 mg/kg) and xylazine
(RompunW, Bayer, Germany 5 mg/kg) were used for
anesthesia. An incision beginning from the sternal
notch and extending to the xiphoid was made in all rats
in accordance with the method defined by Harada et al.
[7]. Flaps were prepared by detaching the skin and the
subdermal tissues from the thoracic wall. Major pectoral
muscle was excised from the thoracic wall. Axillary ar-
tery and vein were preserved. Axillary adipose tissues
were excised; unilateral mastectomy and ALND were
performed (Figure 1). Neither cautery nor chemical sub-
stance was used for hemostasis. Incision was closedBefore
Figure 1 Axillary adipose cellular tissue before and after axillary disseusing 4/0 polyglactin and 4/0 silk. Rats were divided
into two groups including eight rats in each.
In the control group; normal saline, the volume of
which corresponded to the appropriate phenytoin dose
that has been adjusted according to the weight of the
rats, was applied under the flaps, immediately following
abdominal closure. In the phenytoin group; 1% pheny-
toin solution, which had been prepared before, was ap-
plied under the flaps at a dose of 4 mg/kg.
Rats were monitored for 10 days after the surgery. Via-
bility of the flaps, movement of the extremities, wound
healing, wound infection, necrosis seroma formation were
evaluated. On the 10th day postoperatively seroma was
aspirated under anesthesia with needle and recorded.
Relaparotomies were done and remnant seroma was aspi-
rated and measured. Tissue samples from the thoracic
wall and axilla were also obtained for histopathological
examination. They were fixed with 10% formalin solution.
After these procedures, rats were sacrificed by decapita-
tion with a guillotine.
Histopathological examination: After tissue samples
were embedded in paraffin blocks, 5 μm sections were
obtained. Preparations were stained with hematoxylin
and eosin (HE) and with Masson's Trichrome stain to
evaluate fibrosis better. Angiogenesis, edema, necrosis,
congestion and augmentation of fibrous tissue were
examined quantitatively under the light microscope and
were scored as follows: Grade 1: No or mild alteration,
Grade 2: Moderate alterations, Grade 3: Increased altera-
tions, Grade 4: Intensive alterations. Polymorphonuclear
leukocyte (PNL), fibroblast, lymphocyte and macrophage
infiltrations were scored semi-quantitatively as follows:
Grade 1: no or minimal cell infiltration, Grade 2: moder-
ate infiltration, Grade 3: increased infiltration, Grade 4:
intensive infiltration.
Statistical analyses were done using ‘SPSS Data Editor
for Windows version 17.0’ program. Seroma volume
and histopathological parameters were evaluated by
Mann–Whitney U test. A p value of <0.05 was consid-
ered significant.After
ction.
Table 1 Semi-quantitative values of histopathological
findings
Phenytoin Control P value
Vascularity [angiogenesis] 2.75 ± 0.46 3.38 ± 0.52 0.029
Necrosis 1.25 ± 0.70 1.00 ± 0.00 0.317
Congestion 2.50 ± 0.54 2.13 ± 0.35 0.124
PNL 1.50 ± 0.54 1.38 ± 0.52 0.629
Lymphocyte 1.63 ± 0.52 2.13 ± 0.35 0.044
Edema 1.63 ± 0.52 2.25 ± 0.71 0.069
Fibrosis 3.25 ± 0.71 2.25 ± 0.71 0.019
Fibroblast 3.00 ± 0.76 2.88 ± 0.64 0.725
Macrophage 1.25 ± 0.46 2.13 ± 0.64 0.011
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None of the rats developed wound-related problem [de-
hiscence, infection, macroscopic flap necrosis, etc.] or a
problem that would cause their exclusion from the
study. All animals survived. Temporarily movement lim-
itations was observed in the upper extremity at the same
side where mastectomies were done within the post-
operative 3 days.
The mean seroma volume was 1.2 ± 0.11 ml in the
control group, whereas it was 0.51 ± 0.08 ml in the
phenytoin group. This difference was significantly differ-
ent (p = 0.001).
Histopathological findings: Fibrosis was found signifi-
cantly higher (Figure 2) and angiogenesis was found sig-
nificantly lower in the phenytoin group as compared to
the control group (P < 0.05). However, macrophage and
lymphocyte infiltrations were significantly higher in the
control group (P < 0.05). There was no difference be-
tween the groups in terms of necrosis, edema, conges-
tion, or PNL and fibroblast infiltration (Table 1).
Discussion and conclusion
Seroma is a serious fluid collection in a surgical cavity
that is clinically evident. Seroma formation is the most
common complication after mastectomy and occurs at a
rate of 5-52% (mean 30%) under the skin flap or in the
dead-space in the axilla [1-3,6,11].
Pathogenesis of seroma formation is unclear. Analysis
of the seroma that occurred after mastectomy and axil-
lary curettage revealed an exudative fluid including
cellular components of acute inflammation [12]. Dead-
space after mastectomy is initially filled with a fluid
consisting of blood and lymphatic leak. During inflam-
matory process of surgical trauma, polymorphonuclear
leukocytes (PNL) and macrophages migrate to this area
due to the effects of histamine, prostaglandin and adeno-
sine in particular, and the vascular ends, which have
been closed due to vasoconstriction, open and contrib-
ute to the fluid flow. In addition, concentration of sol-
uble particles in the fluid changes with phagocyteControl 
Figure 2 There was also significant microscopic difference between t
enhancement.infiltration. Osmotic pressure gradient occurs when par-
ticle concentration is higher in the seroma than sur-
rounding tissue. Accordingly, it is thought that fluid flow
to this area continues until particle concentrations be-
come equal, and thus, seroma persists [13,14].
Many factors are thought to be associated with seroma
formation after mastectomy and axilla dissection. Kuroi
et al. investigated evidence level of these factors in a re-
view consisted of 51 randomized, 7 prospective and 7
retrospective studies. They reported that seroma forma-
tion was not associated with previous biopsy, type of
drainage (closed suction versus static drainage), duration
of drainage, number of drains, intensity of negative suc-
tion pressure, removal of drains on the fifth postopera-
tive day or when daily drainage volume fell to minimal,
immobilization of shoulder, lymph node status or lymph
node positivity, number of removed lymph nodes, hor-
mone receptor status, and stage. They also reported
moderate level of evidences concerning increased risk
for seroma formation in overweight patients, as well as
in the patients that underwent modified radical mastec-
tomy as compared to simple mastectomy and in the
patients that had higher amount of drainage within the
first three days of surgery [3]. We preferred Harada et al.
method in our experimental study. This is well docu-
mented and frequently used model. Pectoral muscle isPhenytoin
he control and phenytoin groups in terms of fibrous tissue
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about cautery application, due to its hegative impact on
seroma formation. Because of that we tried to abstain
from cautery usage. Cautery application in humans dif-
fers according to surgeons choice. Some prefers cautery
only for the whole procedure. We tried to standardise
our experiment and did not use cautery. All the surger-
ies could have done with the help of coagulation.
Breast surgeries in humans generally needs prophylac-
tic antibiotics. Since these operations are considered as
clean, routine application of antibiotics is not mandatory.
Also in our experimental study we could have seen infec-
tion. Due to its diminished possibility we preferred to ab-
stain from antibiotic usage. There was no infection in
animals.
Numerous methods including surgical techniques
[6,15,16], pressure dressings [17], immobilization [18,19],
closed drain suction devices [20,21], sclerosing agents
[6], and various types of tissue adhesives have been inves-
tigated in terms of their ability to minimize seroma for-
mation. Nevertheless, these methods are not always
effective and may contribute additional morbidity for
patients. Although many studies have shown that surgical
closure of dead-space is an effective method, it has not
been widely accepted since it prolongs surgery by 10 to
20 minutes [22].
Many studies have shown favorable effects of pheny-
toin on wound healing. It was reported in those studies
that phenytoin reduced inflammation, pain, bacterial
contamination and exudate in the wound but augmented
fibroblastic proliferation, granulation tissue formation,
neo-vascularization and collagenization [9,10,23-25]. De-
pending on favorable effects of phenytoin on wound
healing, particularly exudate-reducing effect in the
wound, we decided to conduct the present experimental
study thinking that phenytoin might have seroma-
reducing effect as well. In the present study, the decrease
in seroma volume of the phenytoin group was found sta-
tistically significant (P = 0.001). Histopathological exam-
ination revealed significantly lower angiogenesis and
lymphocyte and macrophage infiltration but significantly
higher fibrosis. The mechanism of seroma preventing ef-
fect of phenytoin is unclear. In the present study, we
observed that phenytoin had anti-inflammatory and
anti-angiogenic but fibrosis enhancing effects. Seroma-
reducing effect of phenytoin might occur from the
above-mentioned effects. Excess fluid collection in the
surgical trauma area may result from excess wound in-
flammation in this area. This hypothesis seems to be
corroborated by the study of Watt-Boolsen et al., which
showed that seroma is a kind of inflammatory exudate
and that seroma formation reflects prolongation and se-
verity of inflammatory phase of wound healing [26]. One
of the significant findings of the present study is reducedangiogenesis in the phenytoin group. It was shown that
vasodilatation is remarkable in the inflammatory phase
of wound healing and plays an important role in extrava-
sation of fluid [27,28]. Prevention of augmentation of
angiogenesis and vasodilatation might reduce seroma
formation due to decreased fluid flow from capillary bed
to dissection area. In their rat model of mastectomy,
Kocdor et al. reported that 5 FU might have reduced ser-
oma due to its anti-inflammatory and anti-angiogenetic
effects [29]. The other significant finding of the present
study is incerasement of fibrosis by phenytoin. Augmen-
ted fibrosis in the surgical area might be important in
terms of adhesion of flaps to the surgical area and filling
of dead-space with fibrosis. In conclusion, local pheny-
toin application reduces seroma formation in the experi-
mental rat model of mastectomy. Mechanism of seroma-
reducing effect of phenytoin and its effect on seroma
formation should be illuminated with the future studies.
We need to apply different doses of phenytoin and
change time of usage.
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